How much does V-Bio typically invest?

V-Bio states a typical cheque of €1M – €5M.

Which stages does V-Bio invest in?

V-Bio invests at Series A, Series B and Seed.

Where is V-Bio based?

V-Bio is headquartered in Ghent, Belgium.

Investor directory

V-Bio

VC fundGhent, Belgiumv-bio.ventures LinkedIn

V-Bio Ventures leverages a strong relationship with the VIB research institute to co-create and invest in life science startups.

What they invest in

Stages

Series A Series B Seed

Sectors

AgriTech Biotech & Pharma Consumer Dev Tools & Cloud B2B SaaS FoodTech Hardware HealthTech

Geographies

Europe

The facts

Typical cheque: €1M – €5M
Headquarters: Ghent, Belgium
Founded: 2015

Portfolio companies

Agomab Therapeutics Aphea.Bio ATB Therapeutics Augustine Therapeutics Avidicure Coave Therapeutics Protealis Step Pharma

More portfolio companies

Orionis BiosciencesAgomab Therapeutics (NAS: AGMB)ExeVirSibylla BiotechFlindr TherapeuticsCorteria PharmaceuticalsMuna TherapeuticsPrecirixOctimet OncologyConfo TherapeuticsOxularDualyxAstriVaxAnimabSyndesi TherapeuticsRootWaveTanai TherapeuticsBiodol TherapeuticsArc TherapeuticsTRIM TX

Recent rounds

Augustine Therapeutics NV
€77.7MSeries AHealthTech
Novo HoldingsleadJeitoleadV-BioAsabys Partners AdBio partnersPMV · +4 more in the source
24 March 2025Belgiumsiliconcanals.com

Rounds V-Bio took part in, as reported by the linked articles. See who else is investing right now.

Questions founders ask

How much does V-Bio typically invest?: V-Bio states a typical cheque of €1M – €5M.
Which stages does V-Bio invest in?: V-Bio invests at Series A, Series B and Seed.
Where is V-Bio based?: V-Bio is headquartered in Ghent, Belgium.

Does V-Bio fit your round?

In 30 minutes you'll know which funds matter for your round.

Request access

Are you V-Bio? Tell us what to correct and we will update it — or ask us to remove the entry.